Abstract | OBJECTIVE: To examine the pro-resolution actions of 15-epi-lipoxin A(4) (LXA(4)) on endometriotic lesions, on the concentrations and activities of matrix metalloproteinases (MMP-2 and MMP-9) in murine endometriosis. DESIGN: Prospective, vehicle-controlled experimental study. SETTING: Animal research facility. ANIMAL(S): BALB/c mice. INTERVENTION(S):
Endometriosis (EM) was induced in 30 mice. Fifteen of them were administered LXA(4) for 24 days (LXA(4) group), whereas the other 15 served as a control group (EM group). Another 15 sham-operated mice ( sham-operated group) were treated with vehicles. MAIN OUTCOME MEASURE(S): The weight of the endometriotic lesions was measured. The concentrations, mRNA, and activities of MMP-2 and MMP-9 were determined by enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and gelatin zymography, respectively. RESULT(S): Compared with EM group, the weight of the endometriotic lesions was decreased, the concentrations of MMP-2 and MMP-9 dropped, the mRNA levels of MMP-2 and MMP-9 in the peritoneal fluid cells and the endometriotic lesions were reduced, and the activities of MMP-2 and MMP-9 were inhibited in the LXA(4) group. CONCLUSION(S): LXA(4) may inhibit the progression of endometriosis possibly by lowering the concentrations and the activities of MMP-2 and MMP-9.
|
Authors | Qiong-Hua Chen, Wei-Dong Zhou, De-Min Pu, Qian-Sheng Huang, Tian Li, Qing-Xi Chen |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 93
Issue 5
Pg. 1440-7
(Mar 15 2010)
ISSN: 1556-5653 [Electronic] United States |
PMID | 19268934
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Lipoxins
- RNA, Messenger
- lipoxin A4
- Matrix Metalloproteinase 2
- Mmp2 protein, mouse
- Matrix Metalloproteinase 9
- Mmp9 protein, mouse
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, pharmacology)
- Ascitic Fluid
(cytology, enzymology)
- Disease Models, Animal
- Disease Progression
- Down-Regulation
- Endometriosis
(drug therapy, enzymology, pathology)
- Endometrium
(drug effects, enzymology, pathology, transplantation)
- Enzyme-Linked Immunosorbent Assay
- Estrus
- Female
- Gene Expression Regulation, Enzymologic
(drug effects)
- Injections, Intraperitoneal
- Lipoxins
(administration & dosage, pharmacology)
- Matrix Metalloproteinase 2
(genetics, metabolism)
- Matrix Metalloproteinase 9
(genetics, metabolism)
- Mice
- Mice, Inbred BALB C
- RNA, Messenger
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
|